Shinpoong Pharmaceutical Co Ltd
KRX:019170
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Dow Inc
NYSE:DOW
|
US |
Shinpoong Pharmaceutical Co Ltd
Accrued Liabilities
Shinpoong Pharmaceutical Co Ltd
Accrued Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Shinpoong Pharmaceutical Co Ltd
KRX:019170
|
Accrued Liabilities
₩6.4B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
5%
|
CAGR 10-Years
5%
|
|
|
Yuhan Corp
KRX:000100
|
Accrued Liabilities
₩33.6B
|
CAGR 3-Years
77%
|
CAGR 5-Years
58%
|
CAGR 10-Years
38%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Accrued Liabilities
₩94.6B
|
CAGR 3-Years
20%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Accrued Liabilities
₩63.7B
|
CAGR 3-Years
4%
|
CAGR 5-Years
9%
|
CAGR 10-Years
0%
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Accrued Liabilities
₩25B
|
CAGR 3-Years
32%
|
CAGR 5-Years
31%
|
CAGR 10-Years
20%
|
|
|
C
|
Caregen Co Ltd
KOSDAQ:214370
|
Accrued Liabilities
₩964.9m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
Shinpoong Pharmaceutical Co Ltd
Glance View
Shinpoong Pharmaceutical Co. Ltd. engages in the manufacture and sales of pharmaceutical products. The company is headquartered in Ansan, Gyeonggi-Do. The firm's product portfolio consists of antibiotics, cardiovascular drugs, anti-cancer drugs, psychoneurotic drugs, antirheumatic drugs, antidiabetics, antifungal agents, antihistamines, antiviral agents, benign prostatic hyperplasia (BPH) drugs and trichogens. The firm also provides active pharmaceutical ingredients (APIs) synthesized by the Company, including non-steroidal anti-inflammatory drugs (NSAIDs), cardiovascular drugs, anti-ulcer drugs, respiratory drugs, antispasmodics drugs and others. The firm distributes its products within domestic market and to overseas markets.
See Also
What is Shinpoong Pharmaceutical Co Ltd's Accrued Liabilities?
Accrued Liabilities
6.4B
KRW
Based on the financial report for Dec 31, 2025, Shinpoong Pharmaceutical Co Ltd's Accrued Liabilities amounts to 6.4B KRW.
What is Shinpoong Pharmaceutical Co Ltd's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
5%
Over the last year, the Accrued Liabilities growth was -29%. The average annual Accrued Liabilities growth rates for Shinpoong Pharmaceutical Co Ltd have been -4% over the past three years , 5% over the past five years , and 5% over the past ten years .
